Trials / Terminated
TerminatedNCT00957788
Safety Study for NST-001 and the Neuroject Injection Set to Treat Tinnitus
Safety and Feasibility Study of NST - 001 in Inner Ear Using Neuroject Injection Set for the Treatment of Tinnitus
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- NeuroSystec Corporation · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This research study involves an experimental drug (NST\_001) and a delivery system. The main purpose of this research study is to investigate the safety of NST-001, delivered directly to the inner ear for the treatment of tinnitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NST-001 | Comparison of different dosages of drug. |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2009-08-12
- Last updated
- 2013-04-22
Locations
2 sites across 2 countries: Belgium, France
Source: ClinicalTrials.gov record NCT00957788. Inclusion in this directory is not an endorsement.